Other languages Apyx Medical Corporation

Equities

APYX

US03837C1062

Delayed Nasdaq Other stock markets 12:44:25 2024-05-02 pm EDT			5-day change	1st Jan Change
1.403 ^USD	+0.24%		-5.18%	-46.44%

Apr. 05	Archon Capital Management Engages with Apyx Medical Corporation	CI
Apr. 01	Stavros G. Vizirgianakis Engages in Discussions with Apyx Medical Corporation	CI

Other languages

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Archon Capital Management Engages with Apyx Medical Corporation	Apr. 05
Stavros G. Vizirgianakis Engages in Discussions with Apyx Medical Corporation	Apr. 01
Apyx Medical Corporation Reports Earnings Results for the Full Year Ended December 31, 2023	Mar. 21
Apyx Medical Corporation Provides Earnings Guidance for the Year Ending December 31, 2024	Mar. 21
Apyx Medical Corporation Reports Earnings Results for the Fourth Quarter Ended December 31, 2023	Mar. 21
Apyx Medical Corporation Announces Peer-Reviewed Clinical Publication Evaluating the Safety of Renuvion® Following Liposuction in Multiple Areas of the Body	Jan. 22
Apyx Medical Reports Q4, Full-Year 2023 Preliminary Revenue	Jan. 08
Apyx Medical Corporation Provides Preliminary Revenue Guidance for the Fourth Quarter and Full Year Ended December 31, 2023	Jan. 08
Apyx Medical Names Matthew Hill as CFO	Nov. 28
Apyx Medical Corporation Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	Nov. 09
Apyx Medical Corporation Revises Earnings Guidance for the Year 2023	Nov. 09
Apyx Medical Corporation Reaffirms Financial Guidance for the Year Ending December 31, 2023	23-08-10
Apyx Medical Corporation Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	23-08-10
Insider Sell: Apyx Medical	23-06-28
Apyx Medical Receives FDA 510(k) Clearance for the Renuvion Micro Handpiece; Shares Rise Pre-Bell	23-06-14
Apyx Medical Corporation Announces FDA 510(k) Clearance for the Renuvion® Micro Handpiece	23-06-14
Apyx Medical Corporation Updates Earnings Guidance for the Year Ending December 31, 2023	23-05-11
Apyx Medical Corporation Reports Earnings Results for the First Quarter Ended March 31, 2023	23-05-11
Apyx Medical Says FDA Clears Renuvion for Specific Use After Liposuction	23-05-02
Sector Update: Health Care Stocks Higher Late Friday Afternoon	23-04-28

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Other languages Apyx Medical Corporation

Equities

APYX

US03837C1062

Other languages

Filters